Effects of valsartan on stress-induced changes of serum vascular endothelial growth factor and nitric oxide in mice

The International Journal of Neuroscience
Bahar ErbaşSemra Doğru-Abbasoğlu

Abstract

This study investigated the effects of renin-angiotensin system (RAS) blockade on stress-induced changes of serum vascular endothelial growth factor (VEGF) and nitric oxide (NO) in mice. Chronic stress increased the serum NO levels significantly compared to control group (p = .0172). Valsartan, an angiotensin II receptor antagonist, alone, did not make significant difference versus control group. In chronic stress + valsartan group, serum NO levels decreased nonsignificantly compared to chronic stress group. There was a nonsignificant increase in serum VEGF levels after chronic stress. Valsartan alone or with chronic stress did not significantly affect the serum VEGF levels. In conclusion, there was no correlation between NO and VEGF changes during the stress response. In this respect, there may be other mechanisms to explain the stress-induced NO increase.

References

Sep 1, 1992·Brain Research. Brain Research Reviews·J W Wright, J W Harding
Feb 25, 1985·Life Sciences·L MilakofskyW H Vogel
Dec 1, 1984·Journal of Hypertension·B G ZimmermanP C Wong
Jan 1, 1994·Neuroscience and Biobehavioral Reviews·J W Wright, J W Harding
Jan 1, 1996·Biological Signals·G YangY Zhu
Aug 1, 1997·American Journal of Respiratory Cell and Molecular Biology·J H PersoonsG Kraal
Feb 12, 1998·The American Journal of Physiology·M E PueyoJ B Michel
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·J Vásquez-VivarK A Pritchard
Mar 2, 1999·Journal of Vascular Research·C BoerP Sipkema
Jun 10, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·I ZacharyJ Martin
Sep 9, 2000·Trends in Pharmacological Sciences·M Colasanti, H Suzuki
Jun 23, 2001·Journal of the American College of Cardiology·F L CellettiM D Dake
Aug 23, 2001·The Journal of Surgical Research·H W Kim, A G Greenburg
Feb 1, 2003·American Journal of Hypertension·Arnfried U KlingbeilRoland E Schmieder
Dec 11, 2003·Atherosclerosis. Supplements·Karsten Sydow, Thomas Münzel
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Stefan Peters

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.